Nautilus Biotechnology Inc. Common Stock (NAUT)
Stock · NASDAQ · Industrials
$0.8828as of 8/28/2026
Price chart
Open in TradingViewActive signals
About NAUT
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution op…
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Employees
- 127
- Website
- www.nautilus.bio
Fundamentals
- 1-day range
- $0.8722$0.9177
- Market cap
- $112.76M
- P/E (trailing)
- —
- P/E (forward)
- -1.20
- EPS (trailing)
- $-0.45
- Dividend yield
- —
- Beta
- 0.76
- Avg. volume
- 859.5K
Forecasts
1 analyst ratings
Nautilus Biotechnology Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- NAUTNautilus Biotechnology Inc. Common Stock$0.8828▼ 2.35%Market cap $112.76MP/E —$0.62$4.31
- SEERSeer Inc. Class A Common Stock$1.99▼ 1.00%Market cap $120.41MP/E —
- RPIDRapid Micro Biosystems Inc. Class A Common Stock$1.56▼ 3.11%Market cap $96.03MP/E —$1.52$4.94
- CIRCCircle8 Group Inc. Common Stock$0.7246▲ 2.34%Market cap $70.73MP/E —$0.4773$0.98
- QTRXQuanterix Corporation Common Stock$2.64▼ 0.00%Market cap $180.42MP/E —
- PRPOPrecipio Inc. Common Stock$28.85▼ 1.50%Market cap $41.93MP/E —$14.28$33.63
- HBIOHarvard Bioscience Inc. Common Stock$7.97▲ 0.82%Market cap $27.92MP/E —$3.8$9.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NAUT Nautilus Biotechnology Inc. Common Stock | $112.76M | — | $0.8828 | ▼ 2.35% | $0.62$4.31 |
| SEER Seer Inc. Class A Common Stock | $120.41M | — | $1.99 | ▼ 1.00% | |
| RPID Rapid Micro Biosystems Inc. Class A Common Stock | $96.03M | — | $1.56 | ▼ 3.11% | $1.52$4.94 |
| CIRC Circle8 Group Inc. Common Stock | $70.73M | — | $0.7246 | ▲ 2.34% | $0.4773$0.98 |
| QTRX Quanterix Corporation Common Stock | $180.42M | — | $2.64 | ▼ 0.00% | |
| PRPO Precipio Inc. Common Stock | $41.93M | — | $28.85 | ▼ 1.50% | $14.28$33.63 |
| HBIO Harvard Bioscience Inc. Common Stock | $27.92M | — | $7.97 | ▲ 0.82% | $3.8$9.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Is Social Media A Bubble? (GS, AMZN, SPMD, YHOO, STVI, PLPE)Benzinga · 8/6/2026
- Nautilus Biotechnology: Contrarian Proteoformics Play After The Recent PullbackSeekingAlpha · 8/3/2026
Insider Activity
Insider Actions →- Epperly Melissa B, · June 18, 2026 · Grant45.0K
- Akinsanya Karen · June 18, 2026 · Grant45.0K
- Matthew L. Posard · June 18, 2026 · Grant45.0K
- McIlwain Matthew S · June 18, 2026 · Grant45.0K
- NAZEM FARZAD · June 18, 2026 · Grant45.0K
- Marc L. Andreessen · June 2, 2026 · Sale384.0K @ $2.35
- Marc L. Andreessen · June 2, 2026 · Sale4.62M @ $2.35
- Patel Sujal M · March 4, 2026 · Buy25.0K @ $2.61
- Suzuki Kentaro · March 2, 2026 · Grant160.0K
- Murphy Matthew B. · March 2, 2026 · Grant160.0K
- Mallick Parag · March 2, 2026 · Grant280.0K
- Mowry Anna · March 2, 2026 · Grant160.0K
- Sankar Subramanian · March 2, 2026 · Grant160.0K
- Weld Gwen E · March 2, 2026 · Grant160.0K
- Patel Sujal M · March 2, 2026 · Grant650.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 54.08M
- Total value held
- $203.14M
- Institutional holders
- 81
- Unknown17.65M
- Unknown12.59M
- Unknown7.17M
- Unknown2.55M
- Unknown2.33M
- Unknown2.21M
- Unknown1.46M
- Unknown1.27M
- Unknown750.0K
- Unknown741.2K
See the full, filterable feed with live charts on the MarketWall dashboard.